statistiche per GIANNATEMPO, PATRIZIA

Distribuzione geografica

Continente	#
EU - Europa	69
NA - Nord America	61
AS - Asia	11
AF - Africa	1
Totale	142

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	61
IT - Italia	55
CN - Cina	7
GB - Regno Unito	4
CZ - Repubblica Ceca	2
FR - Francia	2
IN - India	2
UA - Ucraina	2
AT - Austria	1
GR - Grecia	1
JP - Giappone	1
PL - Polonia	1
SE - Svezia	1
TR - Turchia	1
ZA - Sudafrica	1
Totale	142

Salva come PNG Salva come JPEG

Città	#
Milan	39
Fairfield	14
Woodbridge	11
Houston	8
Santa Cruz	6
Seattle	4
Ashburn	3
Buffalo	3
Cambridge	3
Milpitas	3
Southend	3
Rome	2
San Diego	2
Tianjin	2
Wuhan	2
Ann Arbor	1
Bangalore	1
Beijing	1
Innsbruck	1
Kenmore	1
Muizenberg	1
Nettuno	1
New Delhi	1
Polska	1
Riva	1
Shanghai	1
Takamatsu	1
Totale	117

Salva come PNG Salva come JPEG

Nome	#
Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)), file 1508147	88
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma, file 1223356	20
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation, file 665550	10
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma : a systematic review and meta-analysis of patient outcomes, file 665056	7
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer : an open label, single-group, phase 2 trial, file 663216	5
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy, file 665833	5
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma, file 665315	4
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial, file 417412	3
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer, file 700140	2
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma, file 1208374	1
Biomarker-driven immunotherapy for precision medicine in prostate cancer, file 1987302	1
Totale	146

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	146
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	146

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	1	0	0	0	0	0	0	0	0	0	0	1	0
2019/2020	8	1	0	2	0	0	1	0	0	3	0	0	1
2020/2021	61	5	3	4	1	16	9	5	3	5	7	2	1
2021/2022	41	2	1	4	6	3	4	3	3	3	3	9	0
Totale													146

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

statistiche per GIANNATEMPO, PATRIZIA